Issue 1/2017
Content (14 Articles)
Metastatic melanoma moves on: translational science in the era of personalized medicine
Mitchell P. Levesque, Phil F. Cheng, Marieke I.G. Raaijmakers, Annalisa Saltari, Reinhard Dummer
BRAF plus MEK-targeted drugs: a new standard of treatment for BRAF-mutant advanced melanoma
Paola Queirolo, Francesco Spagnolo
Combining forces: the promise and peril of synergistic immune checkpoint blockade and targeted therapy in metastatic melanoma
David J. Hermel, Patrick A. Ott
Erratum
Erratum to: Combining forces: the promise and peril of synergistic immune checkpoint blockade and targeted therapy in metastatic melanoma
David J. Hermel, Patrick A. Ott
Open Access
Identification, genetic testing, and management of hereditary melanoma
Sancy A. Leachman, Olivia M. Lucero, Jone E. Sampson, Pamela Cassidy, William Bruno, Paola Queirolo, Paola Ghiorzo
Open Access
The biology of uveal melanoma
Adriana Amaro, Rosaria Gangemi, Francesca Piaggio, Giovanna Angelini, Gaia Barisione, Silvano Ferrini, Ulrich Pfeffer
Open Access
NON-THEMATIC REVIEW
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
Salvatore Galdy, Angela Lamarca, Mairéad G. McNamara, Richard A. Hubner, Chiara A. Cella, Nicola Fazio, Juan W. Valle
Clinical
Anesthetic technique and cancer recurrence in oncologic surgery: unraveling the puzzle
Ryungsa. Kim
Clinical
Next generation predictive biomarkers for immune checkpoint inhibition
Yulian Khagi, Razelle Kurzrock, Sandip Pravin Patel